| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPC7 |
TRPC7, TRP7: Short transient receptor potential channel 7 |
0.425 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
0.425 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.425 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
0.425 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.425 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
0.425 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
0.425 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
0.425 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
MICA |
MICA: MHC class I chain-related protein A |
0.425 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
0.425 |
Evidence |
|
| ELA3A |
ELA3A, ELA3: Elastase-3A precursor |
SERPINA3 |
IPI00550991 |
0.425 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
OPN3 |
OPN3, ECPN: Opsin-3 |
0.425 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.425 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
P2RY5 |
P2RY5: P2Y purinoceptor 5 |
0.425 |
Evidence |
|
| SERPINB2 |
SERPINB2, PAI2, PLANH2: Plasminogen activator inhibitor 2 precursor |
HTRA1 |
HTRA1, HTRA, PRSS11: Serine protease HTRA1 precursor |
0.425 |
Evidence |
|
| CYP11A1 |
CYP11A1, CYP11A: Cytochrome P450 11A1, mitochondrial precursor |
POR |
POR, CYPOR: NADPH--cytochrome P450 reductase |
0.425 |
Evidence |
|
| CYP17A1 |
CYP17A1, CYP17, S17AH: Cytochrome P450 17A1 |
POR |
POR, CYPOR: NADPH--cytochrome P450 reductase |
0.425 |
Evidence |
O
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
MICA |
MICA: MHC class I chain-related protein A |
0.425 |
Evidence |
|
| CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
CNTFR |
CNTFR: Ciliary neurotrophic factor receptor alpha precursor |
0.425 |
Evidence |
|
| CSTB |
CSTB, CST6, STFB: Cystatin-B |
CAPN1 |
CAPN1, CANPL1: Calpain-1 catalytic subunit |
0.425 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
FCGRT |
FCGRT, FCRN: IgG receptor FcRn large subunit p51 precursor |
0.425 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
0.425 |
Evidence |
|
| HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
0.425 |
Evidence |
|
| HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
0.425 |
Evidence |
|
| HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.425 |
Evidence |
|